China seeks to expand API trade with India

04/29/2013 | PharmaBiz.com (India)

India has become China's top market for active pharmaceutical ingredients, now estimated at almost $2 billion annually, or almost 15% of its API exports, and many Chinese pharma companies are eager to expand that trade. "China should adopt the high standards of quality and also look to making strides in the generic industry here," said Shi Shengyi, speaking for the China National Pharmaceutical Group Corp., Sinopharm.

View Full Article in:

PharmaBiz.com (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA